ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished

February 12, 1988

RFA Announced On Model For Planning community Prevention Program

October 20, 1978

CCOP Discussion Dominate ACCC Annual Meeting

March 12, 1982

Funding Opportunities

January 10, 2003

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985